These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 39389740)

  • 61. Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
    Elia E; Iannaccone M; D'Ascenzo F; Gallone G; Colombo F; Albani S; Attisani M; Rinaldi M; Boccuzzi G; Conrotto F; Noussan P; De Ferrari GM
    Catheter Cardiovasc Interv; 2022 Jan; 99(1):27-36. PubMed ID: 34028964
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction.
    Martinez CA; Singh V; Londoño JC; Cohen MG; Alfonso CE; O'Neill WW; Heldman AW
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1201-9. PubMed ID: 22511541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Left Ventricular Unloading Before Percutaneous Coronary Intervention is Associated With Improved Survival in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Miyashita S; Banlengchit R; Marbach JA; Chweich H; Kawabori M; Kimmelstiel CD; Kapur NK
    Cardiovasc Revasc Med; 2022 Jun; 39():28-35. PubMed ID: 34824038
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic Significance of Central Pulse Pressure for Mortality in Patients With Coronary Artery Disease Receiving Repeated Percutaneous Coronary Intervention.
    Lin MJ; Chen CY; Lin HD; Lin CS; Wu HP
    Medicine (Baltimore); 2016 Mar; 95(13):e3218. PubMed ID: 27043689
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry.
    Lauten A; Engström AE; Jung C; Empen K; Erne P; Cook S; Windecker S; Bergmann MW; Klingenberg R; Lüscher TF; Haude M; Rulands D; Butter C; Ullman B; Hellgren L; Modena MG; Pedrazzini G; Henriques JP; Figulla HR; Ferrari M
    Circ Heart Fail; 2013 Jan; 6(1):23-30. PubMed ID: 23212552
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Iannaccone M; Franchin L; Hanson ID; Boccuzzi G; Basir MB; Truesdell AG; O'Neill W
    Int J Cardiol; 2022 Sep; 362():47-54. PubMed ID: 35533755
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coronary perfusion pressure and left ventricular hemodynamics as predictors of cardiovascular collapse following percutaneous coronary intervention.
    Buchanan KD; Kolm P; Iantorno M; Gajanana D; Rogers T; Gai J; Torguson R; Ben-Dor I; Suddath WO; Satler LF; Waksman R
    Cardiovasc Revasc Med; 2019 Jan; 20(1):11-15. PubMed ID: 30217626
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of Impella on Coronary Perfusion in Patients With Critical Coronary Artery Stenosis.
    Alqarqaz M; Basir M; Alaswad K; O'Neill W
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e005870. PubMed ID: 29643128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
    Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Real-world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry.
    Schreiber T; Wah Htun W; Blank N; Telila T; Mercado N; Briasoulis A; Kaki A; Kondur A; Munir A; Grines C
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):576-581. PubMed ID: 28417594
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program.
    Gonzalez PE; Hebbe A; Hussain Y; Khera R; Banerjee S; Plomondon ME; Waldo SW; Pfau SE; Curtis JP; Shah SM
    Am J Cardiol; 2024 Jul; 222():39-50. PubMed ID: 38677666
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry.
    Chieffo A; Ancona MB; Burzotta F; Pazzanese V; Briguori C; Trani C; Piva T; De Marco F; Di Biasi M; Pagnotta P; Casu G; Giustino G; Montorfano M; Pappalardo F; Tarantini G;
    EuroIntervention; 2020 Feb; 15(15):e1343-e1350. PubMed ID: 31422925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.
    Thomopoulou S; Manginas A; Cokkinos DV
    Hellenic J Cardiol; 2008; 49(6):382-7. PubMed ID: 19110924
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
    Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impella RP support in refractory right ventricular failure complicating acute myocardial infarction with unsuccessful right coronary artery revascularization.
    Gramegna M; Beneduce A; Bertoldi LF; Pagnesi M; Marini C; Pazzanese V; Camici PG; Chieffo A; Pappalardo F
    Int J Cardiol; 2020 Mar; 302():135-137. PubMed ID: 31866154
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel technique of performing multivessel PCI through an Impella sheath.
    Kumar K; Reddy S; Acharya D; Lotun K
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):117-120. PubMed ID: 31696630
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support.
    Iliodromitis KE; Kahlert P; Plicht B; Hoffmann AC; Eggebrecht H; Erbel R; Konorza TF
    Int J Cardiol; 2011 Nov; 153(1):59-63. PubMed ID: 20826017
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical features and outcomes in patients with cardiogenic shock complicating acute myocardial infarction: early vs recent experience with impella.
    Singh H; Mehta RH; O'Neill W; Kapur NK; Lalonde T; Ohman M; Ghiu I; Chen-Hsing Y; Dutcheshen K; Schreiber T; Rosman H; Kaki A
    Am Heart J; 2021 Aug; 238():66-74. PubMed ID: 33848505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.